Albert Labs International (XCNQ:ABRT) Other Long-Term Liabilities : C$0.00 Mil (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Other Long-Term Liabilities?

Albert Labs International's other long-term liabilities for the quarter that ended in Sep. 2023 was C$0.00 Mil.

Albert Labs International's quarterly other long-term liabilities stayed the same from Mar. 2023 (C$0.00 Mil) to Jun. 2023 (C$0.00 Mil) but then increased from Jun. 2023 (C$0.00 Mil) to Sep. 2023 (C$0.00 Mil).

Albert Labs International Other Long-Term Liabilities Historical Data

The historical data trend for Albert Labs International's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Other Long-Term Liabilities Chart

Albert Labs International Annual Data

Trend

Dec21

Dec22

Other Long-Term Liabilities

Albert Labs International Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Long-Term Liabilities	Get a 7-Day Free Trial					-	-	-	-	-

Albert Labs International Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Albert Labs International Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International (XCNQ:ABRT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6

Website

https://www.albertlabs.com

Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines